Scientists track how CF drugs change Body's salt and lung function
NCT ID NCT04732910
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 500 people with cystic fibrosis who are already taking CFTR modulator medicines. Researchers measure sweat chloride, nasal electrical activity, and rectal tissue responses to see how well the drugs improve CFTR protein function. The goal is to better understand treatment effects, not to test a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité - Universitätsmedizin Berlin
RECRUITINGBerlin, State of Berlin, 13353, Germany
-
Hannover Medical School
RECRUITINGHanover, Germany
-
Justus-Liebig-University Giessen
RECRUITINGGiessen, Germany
-
University of Heidelberg
RECRUITINGHeidelberg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- Can a smartphone app reveal how CF treatments really work at home?
- Can a peer coach help young people take control of their chronic illness?
- Could a single antibiotic be enough for cystic fibrosis lung infections?
- Early use of powerful CF drugs may boost growth in young children
- Hands-On therapy may soothe cystic fibrosis pain without drugs